The Molecular Control of Corpus Luteum Formation, Function, and Regression
Carlos Stocco1,
Carlos Telleria1 and
Geula Gibori
Department of Obstetrics, Gynecology and Reproductive Science (C.S.), Yale University School of Medicine, New Haven, Connecticut 06510; Division of Basic Biomedical Sciences (C.T.), Sanford School of Medicine of the University of South Dakota, Vermillion, South Dakota 57069; and Department of Physiology and Biophysics (G.G.), University of Illinois College of Medicine, Chicago, Illinois 60612
Correspondence: Address all correspondence and requests for reprints to: Dr. Geula Gibori, Department of Physiology and Biophysics, University of Illinois College of Medicine, 835 South Wolcott Avenue, Chicago, Illinois 60612. E-mail: ggibori{at}uic.edu
The corpus luteum (CL) is one of the few endocrine glands thatforms from the remains of another organ and whose function andsurvival are limited in scope and time. The CL is the site ofrapid remodeling, growth, differentiation, and death of cellsoriginating from granulosa, theca, capillaries, and fibroblasts.The apparent raison detre of the CL is the productionof progesterone, and all the structural and functional featuresof this gland are geared toward this end. Because of its uniqueimportance for successful pregnancies, the mammals have evolveda complex series of checks and balances that maintains progesteroneat appropriate levels throughout gestation. The formation, maintenance,regression, and steroidogenesis of the CL are among the mostsignificant and closely regulated events in mammalian reproduction.During pregnancy, the fate of the CL depends on the interplayof ovarian, pituitary, and placental regulators. At the endof its life span, the CL undergoes a process of regression leadingto its disappearance from the ovary and allowing the initiationof a new cycle. The generation of transgenic, knockout and knockinmice and the development of innovative technologies have revealeda novel role of several molecules in the reprogramming of granulosacells into luteal cells and in the hormonal and molecular controlof the function and demise of the CL. The current review highlightsour knowledge on these key molecular events in rodents.
This article has been cited by other articles:
S.-U. Chen, C.-H. Chou, C.-W. Lin, H. Lee, J.-C. Wu, H.-F. Lu, C.-D. Chen, and Y.-S. Yang Signal mechanisms of vascular endothelial growth factor and interleukin-8 in ovarian hyperstimulation syndrome: dopamine targets their common pathways
Hum. Reprod.,
March 1, 2010;
25(3):
757 - 767.
[Abstract][Full Text][PDF]
R S Robinson, K J Woad, A J Hammond, M Laird, M G Hunter, and G E Mann Angiogenesis and vascular function in the ovary
Reproduction,
December 1, 2009;
138(6):
869 - 881.
[Abstract][Full Text][PDF]
M. A. Edson, A. K. Nagaraja, and M. M. Matzuk The Mammalian Ovary from Genesis to Revelation
Endocr. Rev.,
October 1, 2009;
30(6):
624 - 712.
[Abstract][Full Text][PDF]
C. Clapp, S. Thebault, M. C. Jeziorski, and G. Martinez De La Escalera Peptide Hormone Regulation of Angiogenesis
Physiol Rev,
October 1, 2009;
89(4):
1177 - 1215.
[Abstract][Full Text][PDF]
S. T Anderson, N. N M Isa, J. L Barclay, M. J Waters, and J. D Curlewis Maximal expression of suppressors of cytokine signaling in the rat ovary occurs in late pregnancy
Reproduction,
September 1, 2009;
138(3):
537 - 544.
[Abstract][Full Text][PDF]
A. Bachelot, J. Beaufaron, N. Servel, C. Kedzia, P. Monget, P. A. Kelly, G. Gibori, and N. Binart Prolactin independent rescue of mouse corpus luteum life span: identification of prolactin and luteinizing hormone target genes
Am J Physiol Endocrinol Metab,
September 1, 2009;
297(3):
E676 - E684.
[Abstract][Full Text][PDF]
Y. S. Devi, A. Shehu, C. Stocco, J. Halperin, J. Le, A. M. Seibold, M. Lahav, N. Binart, and G. Gibori Regulation of Transcription Factors and Repression of Sp1 by Prolactin Signaling Through the Short Isoform of Its Cognate Receptor
Endocrinology,
July 1, 2009;
150(7):
3327 - 3335.
[Abstract][Full Text][PDF]
G. A. Peters, D. D. Seachrist, R. A. Keri, and G. C. Sen The double-stranded RNA-binding protein, PACT, is required for postnatal anterior pituitary proliferation
PNAS,
June 30, 2009;
106(26):
10696 - 10701.
[Abstract][Full Text][PDF]
F. Jimenez-Krassel, J.K. Folger, J.L.H. Ireland, G.W. Smith, X. Hou, J.S. Davis, P. Lonergan, A.C.O. Evans, and J.J. Ireland Evidence That High Variation in Ovarian Reserves of Healthy Young Adults Has a Negative Impact on the Corpus Luteum and Endometrium During Estrous Cycles in Cattle
Biol Reprod,
June 1, 2009;
80(6):
1272 - 1281.
[Abstract][Full Text][PDF]
F. Gaytan, M. Gaytan, J. M. Castellano, M. Romero, J. Roa, B. Aparicio, N. Garrido, J. E. Sanchez-Criado, R. P. Millar, A. Pellicer, et al. KiSS-1 in the mammalian ovary: distribution of kisspeptin in human and marmoset and alterations in KiSS-1 mRNA levels in a rat model of ovulatory dysfunction
Am J Physiol Endocrinol Metab,
March 1, 2009;
296(3):
E520 - E531.
[Abstract][Full Text][PDF]
Q. Li, F. Jimenez-Krassel, J. J Ireland, and G. W Smith Gene expression profiling of bovine preovulatory follicles: gonadotropin surge and prostanoid-dependent up-regulation of genes potentially linked to the ovulatory process
Reproduction,
February 1, 2009;
137(2):
297 - 307.
[Abstract][Full Text][PDF]
I. Ben-Ami, L. Armon, S. Freimann, D. Strassburger, R. Ron-El, and A. Amsterdam EGF-like growth factors as LH mediators in the human corpus luteum
Hum. Reprod.,
January 1, 2009;
24(1):
176 - 184.
[Abstract][Full Text][PDF]
M. Myers, S. van den Driesche, A. S McNeilly, and W C. Duncan Activin A reduces luteinisation of human luteinised granulosa cells and has opposing effects to human chorionic gonadotropin in vitro
J. Endocrinol.,
November 1, 2008;
199(2):
201 - 212.
[Abstract][Full Text][PDF]
H.-Y. Fan, Z. Liu, N. Cahill, and J. S. Richards Targeted Disruption of Pten in Ovarian Granulosa Cells Enhances Ovulation and Extends the Life Span of Luteal Cells
Mol. Endocrinol.,
September 1, 2008;
22(9):
2128 - 2140.
[Abstract][Full Text][PDF]
A. Anupriwan, M. Schenk, K. Kongmanas, R. Vanichviriyakit, D. Costa Santos, A. Yaghoubian, F. Liu, A. Wu, T. Berger, K. F. Faull, et al. Presence of Arylsulfatase A and Sulfogalactosylglycerolipid in Mouse Ovaries: Localization to the Corpus Luteum
Endocrinology,
August 1, 2008;
149(8):
3942 - 3951.
[Abstract][Full Text][PDF]
R. Gonzalez-Fernandez, E. Martinez-Galisteo, F. Gaytan, J. A. Barcena, and J. E. Sanchez-Criado Changes in the Proteome of Functional and Regressing Corpus Luteum During Pregnancy and Lactation in the Rat
Biol Reprod,
July 1, 2008;
79(1):
100 - 114.
[Abstract][Full Text][PDF]
P. Zhao, A. De, Z. Hu, J. Li, S. M. Mulders, M. D. Sollewijn Gelpke, E.-K. Duan, and A. J. W. Hsueh Gonadotropin Stimulation of Ovarian Fractalkine Expression and Fractalkine Augmentation of Progesterone Biosynthesis by Luteinizing Granulosa Cells
Endocrinology,
June 1, 2008;
149(6):
2782 - 2789.
[Abstract][Full Text][PDF]
E.-S. Park, S. Choi, K. N. Muse, T. E. Curry Jr., and M. Jo Response Gene to Complement 32 Expression Is Induced by the Luteinizing Hormone (LH) Surge and Regulated by LH-Induced Mediators in the Rodent Ovary
Endocrinology,
June 1, 2008;
149(6):
3025 - 3036.
[Abstract][Full Text][PDF]
S.-U. Chen, C.-H. Chou, H. Lee, C.-H. Ho, C.-W. Lin, and Y.-S. Yang Lysophosphatidic Acid Up-Regulates Expression of Interleukin-8 and -6 in Granulosa-Lutein Cells through Its Receptors and Nuclear Factor-{kappa}B Dependent Pathways: Implications for Angiogenesis of Corpus Luteum and Ovarian Hyperstimulation Syndrome
J. Clin. Endocrinol. Metab.,
March 1, 2008;
93(3):
935 - 943.
[Abstract][Full Text][PDF]
N. Ben-Jonathan, C. R. LaPensee, and E. W. LaPensee What Can We Learn from Rodents about Prolactin in Humans?
Endocr. Rev.,
February 1, 2008;
29(1):
1 - 41.
[Abstract][Full Text][PDF]
X. Hou, E. W. Arvisais, C. Jiang, D.-b. Chen, S. K. Roy, J. L. Pate, T. R. Hansen, B. R. Rueda, and J. S. Davis Prostaglandin F2{alpha} Stimulates the Expression and Secretion of Transforming Growth Factor B1 Via Induction of the Early Growth Response 1 Gene (EGR1) in the Bovine Corpus Luteum
Mol. Endocrinol.,
February 1, 2008;
22(2):
403 - 414.
[Abstract][Full Text][PDF]
F. Del Canto, W. Sierralta, P. Kohen, A. Munoz, J. F. Strauss III, and L. Devoto Features of Natural and Gonadotropin-Releasing Hormone Antagonist-Induced Corpus Luteum Regression and Effects of in Vivo Human Chorionic Gonadotropin
J. Clin. Endocrinol. Metab.,
November 1, 2007;
92(11):
4436 - 4443.
[Abstract][Full Text][PDF]
M. C. Peluffo, R. L. Stouffer, and M. Tesone Activity and expression of different members of the caspase family in the rat corpus luteum during pregnancy and postpartum
Am J Physiol Endocrinol Metab,
November 1, 2007;
293(5):
E1215 - E1223.
[Abstract][Full Text][PDF]
C. Stocco, J. Kwintkiewicz, and Z. Cai Identification of regulatory elements in the Cyp19 proximal promoter in rat luteal cells
J. Mol. Endocrinol.,
October 1, 2007;
39(4):
211 - 221.
[Abstract][Full Text][PDF]
L. Miranda-Jimenez and B. D. Murphy Lipoprotein receptor expression during luteinization of the ovarian follicle
Am J Physiol Endocrinol Metab,
October 1, 2007;
293(4):
E1053 - E1061.
[Abstract][Full Text][PDF]